Diagnosis, treatment, and work impact of iron deficiency anemia in a Portuguese urban community.
absenteeism
anemia
iron compounds/therapeutic use
iron deficiency
Journal
Porto biomedical journal
ISSN: 2444-8672
Titre abrégé: Porto Biomed J
Pays: United States
ID NLM: 101707479
Informations de publication
Date de publication:
Historique:
received:
30
12
2019
accepted:
29
03
2020
entrez:
1
8
2020
pubmed:
1
8
2020
medline:
1
8
2020
Statut:
epublish
Résumé
Little is known about iron deficiency anemia (IDA)'s treatment in Portugal. We aim to estimate the proportion of anemia, IDA, and iron deficiency without anemia; characterize the diagnostic procedures and prescription patterns; assess anemia's impact over work absenteeism, in a Local Health Unit. Cross-sectional study that evaluated complete blood counts, iron-containing prescriptions, comorbidities, economic failure, and disability certificates issued in 2015 at the Local Health Unit. We evaluated 62,794 complete blood count. The proportion of anemia was 16.5%, higher in patients with economic failure, pregnant women, and patients with congestive heart failure. Of the patients with anemia 87.8% had not serum iron and/or ferritin dosing, and of those with serum iron/ferritin levels tested 50.6% had IDA. IDA was higher in pregnant women, women aged ≥15 years and in patients with congestive heart failure. Approximately 56.2% of patients with IDA did not receive iron-containing medication, and in 38% of the cases the prescribed dose was subtherapeutic. Of the total iron prescriptions 44.1% were association therapies. Anemia accounted for 5.2% of the disability certificates issued in 2015 (1749 workdays lost). Most patients with anemia are not being adequately evaluated and a major proportion does not undergo treatment or has subtherapeutic doses of iron. These results may explain the anemia's impact on work capacity. This is one of the largest studies on anemia in Portugal. An effort to adapt to the established recommendations is urged, to minimize the consequences of this disease.
Identifiants
pubmed: 32734009
doi: 10.1097/j.pbj.0000000000000064
pii: PBJ-D-20-00002
pmc: PMC7386539
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e064Commentaires et corrections
Type : ErratumIn
Informations de copyright
Copyright © 2020 The Authors. Published by Wolters Kluwer Health, Inc. on behalf of PBJ-Associação Porto Biomedical/Porto Biomedical Society. All rights reserved.
Déclaration de conflit d'intérêts
Sponsorships or competing interests that may be relevant to content are disclosed at the end of this article.The authors declare no conflicts of interest.
Références
Intern Med J. 2016 Apr;46(4):470-8
pubmed: 26841337
Am J Clin Nutr. 2003 Feb;77(2):441-8
pubmed: 12540406
World Health Stat Q. 1985;38(3):302-16
pubmed: 3878044
N Engl J Med. 1993 Dec 2;329(23):1691-5
pubmed: 8179652
Public Health Nutr. 2001 Apr;4(2B):537-45
pubmed: 11683548
N Engl J Med. 2013 Aug 1;369(5):448-57
pubmed: 23902484
Blood. 2006 May 15;107(10):3841-6
pubmed: 16403909
Br J Haematol. 2013 Jun;161(5):639-48
pubmed: 23573815
Hematology Am Soc Hematol Educ Program. 2003;:40-61
pubmed: 14633776
JAMA. 1997 Mar 26;277(12):973-6
pubmed: 9091669
Nutr Clin Pract. 2008 Apr-May;23(2):128-41
pubmed: 18390780
Bull Acad Natl Med. 2005 Nov;189(8):1649-63; discussion 1663-4
pubmed: 16737092
Am J Med. 2002 Sep;113(4):276-80
pubmed: 12361812
Am Fam Physician. 1999 Mar 15;59(6):1598-604
pubmed: 10193599
Ann Intern Med. 1960 Feb;52:378-94
pubmed: 13800263
Baillieres Clin Haematol. 1994 Dec;7(4):787-804
pubmed: 7881154
MMWR Recomm Rep. 1998 Apr 3;47(RR-3):1-29
pubmed: 9563847
Transfus Med Rev. 2014 Jul;28(3):156-66
pubmed: 24931617
Gut. 1993 Aug;34(8):1102-7
pubmed: 8174963
Eur J Heart Fail. 2016 Aug;18(8):891-975
pubmed: 27207191
Br J Clin Pract. 1989 Dec;43(12):451-3
pubmed: 2611108
Therap Adv Gastroenterol. 2011 May;4(3):177-84
pubmed: 21694802